Trials / Terminated
TerminatedNCT01549769
Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
A Multiple-Dose, Open-Label Pharmakokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate the pharmacokinetics and pharmacodynamics of bardoxolone methyl in patients with chronic kidney disease and type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bardoxolone Methyl | Oral, once daily |
Timeline
- Start date
- 2012-04-30
- Primary completion
- 2012-11-30
- Completion
- 2013-10-31
- First posted
- 2012-03-09
- Last updated
- 2025-05-29
Source: ClinicalTrials.gov record NCT01549769. Inclusion in this directory is not an endorsement.